Poisons Standard 2007
PROHIBITION OF SALE, SUPPLY AND USEPROHIBITION OF SALE, SUPPLY AND USE
Start here
Get a plain-English read of PROHIBITION OF SALE, SUPPLY AND USE
Turn the raw legal text into a practical explanation grounded in Poisons Standard 2007.
PROHIBITION OF SALE, SUPPLY AND USE
ABRUS PRECATORIUS (Jequirity) seed or root for therapeutic use.
ACORUS CALAMUS (calamus) for human therapeutic use.
ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination for domestic use:
(a) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous solution or mixture is more than 12.5; or
(b) in liquid or semi-solid automatic dishwashing preparations the pH of which is more than 12.5.
ALLYLISOPROPYLACETYLUREA for therapeutic use.
AMINOPHENAZONE (amidopyrine) and its derivatives for human therapeutic use.
AMYGDALIN for therapeutic use.
ANCHUSA OFFICINALIS for therapeutic use.
ARISTOLOCHIA spp. for therapeutic use.
ARISTOLOCHIC ACID(S) for human therapeutic use.
ASARUM spp. containing aristolochic acid(s) for human therapeutic use.
AZADIRACHTA INDICA (neem) including its extracts and derivatives, in preparations for human internal use except ‘debitterised neem seed oil’.
BASIC ORANGE 31 (2-[(4-aminophenyl)azo]-1,3-dimethyl-1H-imidazolium chloride) in preparations for skin colouration and dyeing of eyelashes or eyebrows.
BITHIONOL for human therapeutic use.
BORAGO OFFICINALIS (Borage) for therapeutic use except the fixed oil derived from the seeds of Borago officinalis.
BRAGANTIA spp. containing aristolochic acid(s) for human therapeutic use.
BUCLOSAMIDE for therapeutic use.
BUNIODYL SODIUM for therapeutic use.
CACALIA spp. for therapeutic use.
CINCHOPHEN and its derivatives for therapeutic use.
CLIOQUINOL and other halogenated derivatives of 8-hydroxyquinoline for human internal use except when being used solely for experimental purposes in humans and such use:
(a) is in accordance with an approval granted under paragraph 19(1)(b), and the requirements of subsection 19(4A), of the Therapeutic Goods Act 1989 (as amended from time to time) - otherwise known as the Clinical Trial Exemption (CTX) scheme; or
(b) is in accordance with the requirements of subsection 18(1) of the Therapeutic Goods Act 1989 and Regulation 12(1A) of the Therapeutic Goods Regulations 1990 (as amended from time to time) - otherwise known as the Clinical Trial Notification (CTN) scheme.
COAL TAR for cosmetic use other than in therapeutic goods.
CONIUM MACULATUM (coniine) for therapeutic use.
COTARNINE for therapeutic use.
CROTALARIA spp. for therapeutic use.